Aura Biosciences names Natalie Holles as CEO
Source: SeekingAlpha
2026-05-04 06:17:59 ET
More on Aura Biosciences
- Seeking Alpha’s Quant Rating on Aura Biosciences
- Historical earnings data for Aura Biosciences
- Financial information for Aura Biosciences
Read the full article on Seeking Alpha
For further details see:
Aura Biosciences names Natalie Holles as CEO
Aura Biosciences Inc.
NASDAQ: AURA
AURA Trading
0.22% G/L:
$6.88 Last:
198,710 Volume:
$7.04 Open:
AURA Latest News
June 01, 2026 08:00:00 am
Aura Biosciences Announces Enrollment Completion in Phase 3 CoMpass Trial of Bel-sar in Early Choroidal Melanoma
May 19, 2026 04:50:52 pm
Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 11, 2026 04:01:00 pm
Aura Biosciences Reports First Quarter 2026 Financial Results and Business Highlights
AURA Stock Data
$357,523,404
49,469,047
0.85%
51
N/A
Biotechnology & Life Sciences
Healthcare
US
Boston
